Ekso Bionics sells 2.97M shares at $1.55 in registered direct offering

Ekso Bionics announced that it has entered into a securities purchase agreement with certain institutional investors for the purchase and sale of 2,967,742 shares of common stock at a purchase price of $1.55 per share pursuant to a registered direct offering, resulting in total gross proceeds of approximately $4.6M before deducting placement agent commissions and other offering expenses. The closing of the offering is expected to occur on or about January 16, subject to the satisfaction of customary closing conditions. The company intends to use the net proceeds from the offering for working capital and general corporate purposes. A.G.P./Alliance Global Partners is acting as the sole placement agent for the offering.